The 2nd Golden Helix Pharmacogenomics day was held in the auditorium of the School fo Dentistry of the Aristotle University of Thessaloniki in Greece. Over 120 participants followed this educational event that revolved around the promise of pharmacogenomics in modern medical practice, with special focus on cancer therapeutics.
Organized by: Endorsed by:
The 2nd Golden Helix Pharmacogenomics day was held in the auditorium of the School fo Dentistry of the Aristotle University of Thessaloniki in Greece. Over 120 participants followed this educational event that revolved around the promise of pharmacogenomics in modern medical practice, with special focus on cancer therapeutics.
Organized by: Endorsed by:
Co-organizers
George P. Patrinos; Assistant Professor, University of Patras Department of Pharmacy, Patras, Greece
Charalambos Andreadis; Associate Director, 3rd Clinical Oncology Unit, Theagenio hospital, Thessaloniki, Greece
Asterios Tsiftsoglou; Professor, Aristotle University of Thessaloniki, Department of Pharmacy, Thessaloniki, Greece
Invited speakers
Sotiria Boukouvala (Alexandroupoli, Greece)
Evangelos Briasoulis (Ioannina, Greece)
Evangelos Manolopoulos (Alexandroupolis, Greece)
Konstantinos Papazissis (Thessaloniki, Greece)
George P. Patrinos (Patras, Greece)
Marios Phylactides (Nicosia, Cyprus)
Maria Samara (Larissa, Greece)
Despina Sanoudou (Athens, Greece)
Ioannis Vizirianakis (Thessaloniki, Greece)
Scientific Program
11:00-12:00 Registration
12:00-12:10 Welcome addresses
1st SESSION – Chairpersons: George P. Patrinos, Asterios Tsiftsoglou
12:10-12:40 Despina Sanoudou; Researcher C’, Biomedical research Foundation of the Academy of Athens, Greece
From Pharmacology and Genomics to Pharmacogenomics
12:40-13:10 Evangelos Manolopoulos; Associate Professor, Demoritus University of Thrace, School of Medicine, Alexandroupolis, Greece
Pharmacogenomics in clinical practice: Where are we standing today?
13:10-13:40 Ioannis Vizirianakis; Associate Professor, Aristotle University of Thessaloniki, Department of Pharmacy, Thessaloniki, Greece
Pharmacogenomcs and individualization of drug treatment
13:40-14:10 Sotiria Boukouvala; Lecturer, Democritus University of Thrace, Department of Molecular Biology and Genetics, Alexandroupolis, Greece
Pharmacogenomics: Applications in drug development or just in clinical practice?
COMPANY LECTURE
14:10-14:30 Foteini Papageorgiou; Roche Diagnostics Hellas, Athens, Greece
Therascreen K-ras & EGFR kits: Molecular Diagnostics in individualized treatment
COFFEE BREAK
2nd SESSION – Chairpesons: Charalambos Andeadis, Konstantinos Papazissis
14:50-15:20 Evangelos Briasoulis; Associate Professor, University of Ioannina, School of Medicine, Ioannina, Greece
Every patient is different: Pharmacogenomics and cancer treatment
15:20-15:50 Konstantinos Papazissis; Resident, 3rd Clinical Oncology Unit, Theagenio Hospital, Thessaloniki, Greece
Pharmacogenomics and breast cancer
15:50-16:20 Maria Samara; Lecturer, University of Thessaly, School of Medicine, Larissa, Greece
Pharmacogenomics and colorectal cancer
16:20-16:50 Marios Phylactides; Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
Pharmacogenomics and hemoglobinopathies
16:50-17:20 George P. Patrinos; Assistant Professor, University of Patras, Department of Pharmacy, Patras, Greece
Personalized Medicine: Challenges and dilemmas
17:20-17:30 Concluding remarks
Sponsors
The Organizing Committee acknowledges the support of the following entities for the organization of the 2nd Golden Helix Pharmacogenomics Day.
